The three HMMR SNPs that were identified by our pathway-based analysis were missed in the GWAS for CIN, probably because those SNPs did not directly contribute to CIN in breast cancer patients but rather through the expression of TNFSF13B. The gene discussed is TNFSF13B; the disease is breast carcinoma.